raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:2030

Fibrosarcoma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

Orphadata ships no English definition for this code.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFibrosarcoma
frFibrosarcome
deFibrosarkom
esFibrosarcoma
itFibrosarcoma
nlFibrosarcoom
ptFibrossarcoma
plWłókniakomięsak
csFibrosarkom
ukФібросаркома
zh纤维肉瘤
trFibrosarkom
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C49.9NTBTindexvalidated
MONDO0005164Evalidated
MeSHD005354Evalidated
UMLSC0016057Evalidated
GARD2327Evalidated
MedDRA10016632Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ETV6Part of a fusion gene inAssessedHGNC:3495ENSG0000013908360061812p13.2ETS variant transcription factor 6
NTRK3Part of a fusion gene inAssessedHGNC:8033ENSG0000014053819131615q25.3neurotrophic receptor tyrosine kinase 3
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 0000.01 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card